Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Latitude 360, Inc. (LATX): Redefining the Family Entertainment Center Concept via Ultimate Upscale Multidimensional Entertainment Eatery Model

The rapid evolution of home entertainment in recent years, culminating in home theatre technologies like soon-to-be-released Ultra HD Blu-ray players, massive 102-inch 4K TVs and hi-res audio, as well as the proliferation of diverse interactive games delivered by next-gen consoles and powerful computer display hardware like NVIDIA (NASDAQ: NVDA) graphics cards, has put considerable competitive […]

Solar3D, Inc. (SLTD) Signs Agreement to Acquire Elite Solar

Solar3D, a provider of solar power solutions and the developer of a proprietary high efficiency solar cell, announced that it has inked a definitive agreement to acquire 100% of Elite Solar, a Durham, California-based solar systems provider. The purchase is a continuation of Solar3D’s aggressive growth-by-acquisition strategy, which is intended to boost the company’s top […]

Well Power, Inc. (WPWR) – Promoting Clean Energy Solutions

Well Power is seeking to engage the attention of oil and gas producing companies in its operations. To accomplish this, the company is employing a two-pronged approach: (1) it is aiming to educate them about the unique micro-refinery unit it is backing; and (2) it is working on creating partnership opportunities that make these companies […]

International Stem Cell Corp. (ISCOD) Preparing to Initiate Clinical Development for the Treatment of Parkinson’s Disease in Australia

International Stem Cell Corp. recently took a significant step toward expanding its clinical pipeline when it submitted preclinical data to the Australian Therapeutic Goods Administration (TGA) regarding its impending phase I/IIa clinical trial for the treatment of Parkinson’s disease. According to the submitted data, the company’s nine month study of 300 rodents resulted in no […]

Wisdom Homes of America, Inc. (WOFA) Experiences Faster Turn Cycles and Higher Revenue Transactions as Land/Home Buyers Increase

Wisdom Homes of America, an owner and operator of manufactured homes retail centers, has positioned itself to provide homebuyers the opportunity to purchase quality, affordable manufactured homes. “We previously stated that our goal was to expand into land/home transactions, which is exactly what we’ve done. We’re now closing land/home transactions, and our 90 day pipeline […]

 

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.